In five Central Asian countries, most of pharmaceutical products are imported from foreign countries. Following several years of hard work, we have helped customers produce pharmaceutical companies in these countries provide affordable products to domestic users. In Kazakhstan, we built a large integrated pharmaceutical factory, including two soft bag IV-solution production lines and four ampoules injection production lines.
In Uzbekistan, we built a PP bottle IV-solution pharmaceutical factory capable of producing 18 million bottles annually. The factory not only brings them considerable economic benefits, but also gives the local people access to more affordable medical treatment.
In Russia, although the pharmaceutical industry is well established, much of the equipment and technology used are outdated. After multiple visits to European and Chinese equipment suppliers, the largest injection solution pharmaceutical manufacturer in the country chose us for their PP bottle IV-solution project. The facility can produce 72 million PP bottles per year.
In Africa, many nations are in a stage of developing and many people do not have sufficient healthcare access. Currently, we are building a soft bag IV-solution pharmaceutical factory in Nigeria, capable of producing 20 million soft bags per year. We look forward to producing more high-class pharmaceutical factories in Africa. Our hope is to help the people of Africa by providing equipment that will result in safe pharmaceutical products.
The pharmaceutical industry in the Middle East is still in its infancy, but they have been referring to standards put forth by the FDA in the US for the quality of medical products. On of our customers from Saudi Arabia issued an order for a complete soft bag IV-solution turnkey project that can produce more than 22 million soft bags yearly.
In other Asian countries, the pharmaceutical industry has a solid foundation, but many companies struggle with establishing high-quality IV-solution factories. One of our Indonesian customers, after rounds of selection, chose to process a high-class IV-solution pharmaceutical factory. We have finished phase 1 of the turnkey project which enables the production of 8000 bottles/hour. Phase 2 that will enable 12,000 bottles/hour began installation in late 2018.